Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours

Latest findings from clinical trials in lung cancer with technologically advanced ADCs

Date

22 Sep 2020

Session

Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours

Presenters

Pasi Jänne

Authors

P.A. Jänne

Author affiliations

  • Lowe Center For Thoracic Oncology, Dana Farber Cancer Institute, 2215 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Pasi Jänne

Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours

Resources:

Webcast

Summary and close

Presenter: Pasi Jänne

Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.